1 year return (CAGR)
-53.68%
Aligos Therapeutics Inc Exchange (NASDAQ, USD)
ALGS
5.04
-0.18 (-3.45%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-38.34%
5 year return (CAGR)
-58.84%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
27.44M
Price/Sales
0.87
Ent value
31.50M
Price/Book
0.86
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-61.01%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.17 |
| Daily high | 5.27 |
| Daily low | 5.02 |
| Daily Volume | 28K |
| All-time high | 873.50 |
| 1y analyst estimate | 56.29 |
| Beta | 2.28 |
| EPS (TTM) | -7.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALGS | S&P500 | |
| Current price drop from All-time high | -99.42% | -2.19% |
| Highest price drop | -99.54% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -84.58% | -10.68% |
| Avg time to new high | 71 days | 12 days |
| Max time to new high | 1419 days | 1805 days |
News
